JP2010523264A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523264A5
JP2010523264A5 JP2010503052A JP2010503052A JP2010523264A5 JP 2010523264 A5 JP2010523264 A5 JP 2010523264A5 JP 2010503052 A JP2010503052 A JP 2010503052A JP 2010503052 A JP2010503052 A JP 2010503052A JP 2010523264 A5 JP2010523264 A5 JP 2010523264A5
Authority
JP
Japan
Prior art keywords
heart
pattern
composition
occlusive agent
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010503052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523264A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004613 external-priority patent/WO2008127607A2/en
Publication of JP2010523264A publication Critical patent/JP2010523264A/ja
Publication of JP2010523264A5 publication Critical patent/JP2010523264A5/ja
Pending legal-status Critical Current

Links

JP2010503052A 2007-04-11 2008-04-10 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング Pending JP2010523264A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92293007P 2007-04-11 2007-04-11
US93410907P 2007-06-11 2007-06-11
US93411107P 2007-06-11 2007-06-11
US93404207P 2007-06-11 2007-06-11
PCT/US2008/004613 WO2008127607A2 (en) 2007-04-11 2008-04-10 Cardiac repair, resizing and reshaping using the venous system of the heart

Publications (2)

Publication Number Publication Date
JP2010523264A JP2010523264A (ja) 2010-07-15
JP2010523264A5 true JP2010523264A5 (https=) 2011-05-19

Family

ID=39864585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503052A Pending JP2010523264A (ja) 2007-04-11 2008-04-10 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング

Country Status (6)

Country Link
US (2) US7875017B2 (https=)
EP (1) EP2146667A2 (https=)
JP (1) JP2010523264A (https=)
AU (1) AU2008239681B2 (https=)
CA (1) CA2682160C (https=)
WO (1) WO2008127607A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502372A (ja) * 2006-09-08 2010-01-28 シンフォニー メディカル， インコーポレイテッド 心臓の局所的な異常の治療のための心筋内パターン形成
WO2008127607A2 (en) * 2007-04-11 2008-10-23 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
WO2008154033A2 (en) * 2007-06-11 2008-12-18 Symphony Medical, Inc. Cardiac patterning for improving diastolic function
US9238046B2 (en) 2007-09-21 2016-01-19 The Trustees Of The University Of Pennsylvania Prevention of infarct expansion
US20090259210A1 (en) * 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system
US20120041393A1 (en) * 2008-09-05 2012-02-16 Henry Ford Health System Apparatus and Method for Capsule Formation in Tissue
EP3246038B1 (en) 2008-09-30 2021-04-07 The Regents of the University of California Compositions comprising decellularized extracellular matrix obtained from cardiac tissue
KR101670099B1 (ko) 2008-10-06 2016-10-27 가부시끼가이샤 쓰리디 매트릭스 조직 폐색제
US10143455B2 (en) 2011-07-20 2018-12-04 Covidien LLP Enhanced ultrasound visualization of intravascular devices
EP2398402B1 (en) 2009-02-20 2016-04-20 Covidien LP Devices for venous occlusion for the treatment of venous insufficiency
CA2808225C (en) 2010-08-24 2019-02-12 The Regents Of The University Of California Compositions and methods for cardiac therapy
WO2013036708A2 (en) 2011-09-07 2013-03-14 The Regents Of The University Of California Compositions and methods for tissue repair with extracellular matrices
US9168352B2 (en) 2011-12-19 2015-10-27 Cardiacassist, Inc. Dual lumen cannula
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
AU2015229549B2 (en) 2014-03-10 2019-05-23 3-D Matrix, Ltd. Self-assembling peptide compositions
EP3698815B1 (en) 2014-03-21 2024-02-21 University of Pittsburgh- Of the Commonwealth System of Higher Education Terminally sterilized hydrogel derived from extracellular matrix
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
US11406736B2 (en) 2016-01-13 2022-08-09 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Vascular extracellular matrix hydrogel
WO2019099863A1 (en) * 2017-11-17 2019-05-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Scaffolds having material properties optimized for cardiac applications and uses thereof
AU2018448387A1 (en) * 2018-11-07 2021-04-29 Baxter Healthcare Sa Dual check valve one handed applicator
US20240299018A1 (en) * 2023-03-07 2024-09-12 Medtronic, Inc. Occlusion device
WO2025250182A1 (en) * 2024-05-29 2025-12-04 Lifebridge Technologies Llc Heart pump that structures end-diastolic ventricular geometry for optimal filling and ventricular pump function

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US6132451A (en) 1995-06-07 2000-10-17 Eclipse Surgical Technologies, Inc. Optical fiber for myocardial channel formation
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
WO1997016169A1 (en) 1995-11-01 1997-05-09 Chiron Corporation Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space
EP1707233A3 (en) 1996-02-02 2006-12-20 Medtronic Vascular, Inc. Apparatus for blocking flow through blood vessels
IL118376A0 (en) 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
AU4648697A (en) 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US6183411B1 (en) 1998-09-21 2001-02-06 Myocor, Inc. External stress reduction device and method
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6406420B1 (en) 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6045565A (en) 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6511477B2 (en) 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
KR20010012313A (ko) 1997-05-06 2001-02-15 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 혈관형성성 트랜스유전자의 생체내 송달에 의한 심장 질환및 심실 리모델링을 치료하기 위한 방법 및 조성물
US7031775B2 (en) 1997-11-07 2006-04-18 Medtronic, Inc. Method and system for myocardial infarction repair
US6096021A (en) 1998-03-30 2000-08-01 The University Of Virginia Patent Foundation Flow arrest, double balloon technique for occluding aneurysms or blood vessels
US6085754A (en) 1998-07-13 2000-07-11 Acorn Cardiovascular, Inc. Cardiac disease treatment method
US6547821B1 (en) 1998-07-16 2003-04-15 Cardiothoracic Systems, Inc. Surgical procedures and devices for increasing cardiac output of the heart
US6360749B1 (en) 1998-10-09 2002-03-26 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US6685627B2 (en) * 1998-10-09 2004-02-03 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
JP2002531217A (ja) 1998-12-04 2002-09-24 チャンドラシェカー ピー． パサック， 生体適合性架橋ポリマー
US6689103B1 (en) 1999-05-07 2004-02-10 Scimed Life System, Inc. Injection array apparatus and method
CA2378643A1 (en) 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair
US20030113301A1 (en) 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
US6709427B1 (en) 1999-08-05 2004-03-23 Kensey Nash Corporation Systems and methods for delivering agents into targeted tissue of a living being
US6926689B2 (en) 2002-03-13 2005-08-09 Albertus Scheule Aortic balloon occlusion cannula
US6575932B1 (en) 1999-12-02 2003-06-10 Ottawa Heart Institute Adjustable multi-balloon local delivery device
US6508824B1 (en) 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
JP2004505886A (ja) 2000-02-18 2004-02-26 スィーヴィー　セラピューティクス　インコーポレイテッド 鬱血性心不全の処置における部分的な脂肪酸酸化阻害剤
US6537198B1 (en) 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6585716B2 (en) 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
US6730016B1 (en) 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
EP1311657A2 (en) 2000-08-21 2003-05-21 Rice University Tissue engineering scaffolds promoting matrix protein production
US7491385B2 (en) 2001-09-05 2009-02-17 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
US20020077687A1 (en) 2000-12-14 2002-06-20 Ahn Samuel S. Catheter assembly for treating ischemic tissue
US6620095B2 (en) 2000-12-22 2003-09-16 Syde A. Taheri Cradle-assisted myocardial repair and treatment
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US20040214760A1 (en) 2001-01-15 2004-10-28 Ramesh Gupta Inhibition pf protein-phosphatases for the treatment of heart failure
US20030211793A1 (en) 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
WO2002087481A1 (en) * 2001-04-27 2002-11-07 Myomend, Inc. Prevention of myocardial infarction induced ventricular expansion and remodeling
US7311731B2 (en) 2001-04-27 2007-12-25 Richard C. Satterfield Prevention of myocardial infarction induced ventricular expansion and remodeling
US20020188170A1 (en) 2001-04-27 2002-12-12 Santamore William P. Prevention of myocardial infarction induced ventricular expansion and remodeling
CA2453658C (en) 2001-07-16 2013-04-16 Relaxis Ltd. In-vivo method and device for improving diastolic function of the left ventricle
EP1420702B1 (en) 2001-08-31 2005-04-20 Boston Scientific Limited Percutaneous pringle occlusion device
CA2465672A1 (en) 2001-09-19 2003-03-27 Henry Ford Health System Cardiac transplantation of stem cells for the treatment of heart failure
IL161862A0 (en) 2001-11-08 2005-11-20 Univ California Methods and compositions for correction of cardiac conduction disturbances
CN1649641A (zh) 2002-05-08 2005-08-03 加利福尼亚大学董事会 形成非切除性心脏传导阻滞的系统和方法
AU2003237824B9 (en) 2002-05-08 2008-06-19 The Regents Of The University Of California System and method for treating cardiac arrhythmias with fibroblast cells
US20040106896A1 (en) 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
AU2003234520A1 (en) 2002-05-08 2003-11-11 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
JP4224608B2 (ja) * 2002-11-19 2009-02-18 学校法人日本大学 注入療法用装置
CA2513726C (en) 2003-01-27 2014-08-12 Corassist Cardiovascular Ltd. In vivo device for improving diastolic ventricular function
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
CN100393367C (zh) 2003-05-05 2008-06-11 宾-古里安尼格夫大学研究及发展部 可注射的交联聚合制剂及其应用
EP1786502A2 (en) 2004-07-15 2007-05-23 Incumed Device and method for treating a blood vessel
SG156681A1 (en) 2004-11-09 2009-11-26 Cv Therapeutics Inc Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
US7226440B2 (en) 2005-01-31 2007-06-05 G & L Consulting, Llc Method and device for accessing a pericardial space
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20060253068A1 (en) 2005-04-20 2006-11-09 Van Bilsen Paul Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
WO2007002554A2 (en) 2005-06-23 2007-01-04 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070093748A1 (en) 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070172472A1 (en) 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
US20070100199A1 (en) * 2005-11-03 2007-05-03 Lilip Lau Apparatus and method of delivering biomaterial to the heart
US20080138416A1 (en) 2006-06-13 2008-06-12 Fmc Biopolymer As Method and systems for using biopolymer-based beads and hydrogels
JP2010502372A (ja) 2006-09-08 2010-01-28 シンフォニー メディカル， インコーポレイテッド 心臓の局所的な異常の治療のための心筋内パターン形成
WO2008127607A2 (en) 2007-04-11 2008-10-23 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
US20090259210A1 (en) 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system

Similar Documents

Publication Publication Date Title
JP2010523264A5 (https=)
JP2010502371A5 (https=)
US20070042016A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
US20070093748A1 (en) Methods and systems for treating injured cardiac tissue
JP5522664B2 (ja) 全体的な心臓のサイズ変更および再形成のための心筋内パターン形成
US20070172472A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
JP2004337400A (ja) 薬剤投与キット
CN107049232A (zh) 一种贴附式心脏功能监测和/或干预系统
JP2010502369A5 (https=)
US20100152531A1 (en) Implantable medical device for drug delivery and method of use
US11197944B2 (en) Compositions and methods of mechanically inducing tissue regeneration
Bahramian et al. The effects of exercise training intensity on the expression of C/EBPβ and CITED4 in rats with myocardial infarction
WO2007112135A2 (en) Methods and systems for treating injured cardiac tissue
CN208243663U (zh) 一种作为血管支架外包的纳米药物缓释装置
JP2021512148A5 (https=)
CN206424057U (zh) 一种贴附式心脏功能监测和/或干预系统
CN119080908B (zh) 一种预防或治疗心肌缺血再灌注损伤的多肽及其应用
CN118787731B (zh) Ptma短肽在制备心梗治疗药物中的应用
US20220288369A1 (en) Targeted drug delivery devices and methods
EP1912594A2 (en) Methods and systems for treating injured cardiac tissue
RU2538044C1 (ru) Способ защиты миокарда во время операции протезирования аортального клапана в условиях искусственного кровообращения
Shiojima et al. Disruption of coordinated tissue growth and angiogenesis in the heart contributes to the progression from adaptive hypertrophy to heart failure
JP2009120625A (ja) 安定したｔ３の組成物およびその使用方法
EP3856249A1 (en) Treatment of myocardial infarction
Matsusaka et al. Target deletion of matrix metalloproteinase-2 attenuates cardiac remodeling and failure in mice with chronic pressure overload